SUNRISE aims to create a comprehensive, engaging, and sustainable digital health promotion program that not only addresses immediate health behaviours but also instills lifelong healthy habits among adolescents. By integrating cutting-edge digital tools with traditional educational settings, SUNRISE seeks to bridge the gap between knowledge and practice, making cancer prevention a tangible and achievable goal for young people. This study represents a significant step towards reducing the future burden of cancer through early and innovative preventive measures.
The SUNRISE project aims to test its intervention on students across eight European countries, including Greece, Switzerland, Slovenia, Spain, Cyprus, Italy, Belgium, and Romania. This study focuses on integrating digitally enhanced programs into the school environment, targeting students aged 10 to 19 years. The program emphasizes inclusivity, ensuring participation from both urban and rural regions and socially disadvantaged groups such as ethnic minorities and migrants. By addressing diverse socio-economic, cultural, and environmental contexts, SUNRISE aspires to create a universally applicable and impactful intervention.
Specifically, this study is focus on the SmartCoach program, developed by the Swiss Research Institute for Public Health and Addiction (ISGF). It is a mobile phone-based life-skills training program designed to prevent substance use among adolescents. It will integrate digital tools and leveraging social media creating a more engaging, effective and sustainable intervention for adolescent health behaviour change.
The SmartCoach solution will be significantly more effective than an assessment-only approach in preventing the initiation and escalation of problematic alcohol and tobacco use. This efficacy will be demonstrated through a two-arm cluster-randomized controlled trial, with participants assessed at baseline, 6 months, and 18 months. The study will measure key outcomes related to substance use frequencies, intensities, and associated behavioral changes, showing that the individually tailored 4 month intervention program leads to greater reductions in these behaviors compared to the control group over the 18-month follow-up period.
Minimum Age: Students must be at least 14 years old at the time of enrolment.
Mobile Device and Internet Access: Students must have access to a smartphone and the Internet.
Informed Consent: Students must provide their signed informed consent to participate in the study.
Parental Consent: Students must obtain and submit signed informed consent from a parent or legal guardian.
Age Restrictions: Students who are younger than 14 years or older than the established age range for participation.
Consent Issues: Students who have not signed the informed consent form or do not have signed informed consent from their parents or legal guardians.
Follow-up Limitations: Students who are unable to commit to the follow-up period of at least 18 months or are unlikely to complete the study.
Biobizkaia Health Research Institute
Lead sponsor
University Ghent
Collaborator
FEDERAZIONE ITALIANA DELLE ASSOCIAZIONI DI VOLONTARIATO IN ONCOLOGIA
Collaborator
Hellenic Mediterranean University
Collaborator
University of Zurich
Collaborator
FISABIO (Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community)
Collaborator
Cyprus Association of Cancer Patients and Friends (PASYKAF)
Collaborator
Alma Mater Europaea University
Collaborator
The Oncology Institute "Prof. Dr. Ion Chiricuţă" Cluj-Napoca
Collaborator